Hemophilia Mobile App Usability Pilot

Healthcare Innovation Technology Lab

Status: Unknown

Conditions: Hemophilia

Treatments: Device: SureSource Engage application

Study type: Interventional

Funder types: Industry

Identifiers

NCT03168685

Pro00021564

Details and patient eligibility

About

The purpose of this study is to evaluate the utility and user experience of a smart phone app for people with medical conditions, used in conjunction with an ActiGraph wearable device and a connected scale.

Full description

HITLAB will conduct a segmented rapid user acceptance study ("rapid UX study") of a smart phone app and an actigraphy device with a connected scale. During the first segment, of one month's duration, subjects will use the app, actigraphy device, and scale. Next, over an interphase period of up to 6 weeks, subjects will only use the app. During this time, the app will be modified based on data collected during the first segment. Finally, during the second period, also of one month's duration, subjects will use the modified app, actigraphy device, and scale.

Enrollment: 20 estimated patients

Sex: All

Ages: 18 to 63 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. You own an iPhone or a Samsung (S5 or higher) smartphone
2. Your age is between 18 and 63 years
3. You reside in the New York metropolitan area
4. You are able to read, write, and speak English
5. You have participated in a concluded clinical trial in the past two years

Exclusion criteria

1. You do not own an iPhone or a Samsung (S5 or higher) smartphone
2. Your age is not between 18 and 63 years
3. You do not reside in the New York metropolitan area
4. You are not able to read, write, and speak English
5. You have not participated in a concluded clinical trial in the past two years

Trial design

Primary purpose: Device Feasibility

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

20 participants in 1 patient group

Experimental

Experimental group

Description:

Multiple device intervention 1. SureSource Engage mobile application 2. ActiGraph Link 3. weight scale

Treatment:

Device: SureSource Engage application